Patents by Inventor Marian Brandle

Marian Brandle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITION OF TRISTETRAPROLINE FOR PROTECTION OF THE HEART FROM CARDIAC INJURIES
    Publication number: 20090104182
    Abstract: The present invention relates to compounds suitable for the treatment of conditions which may be improved, at least in part, by increasing TNF ? production. The invention further relates to assays for the identification of an individual at increased risk for or suffering front such conditions and to methods of screening compounds for their ability to enhance TNF ? biosynthesis.
    Type: Application
    Filed: September 26, 2008
    Publication date: April 23, 2009
    Inventors: Franz-Werner KLUXEN, Bernd HENTSCH, Thomas EHRING, Marian BRANDLE, Jorg HOHEISEL, Marcus FROHME, Dimitri ZUBAKOV
  • Inhibition of tristetraproline for protection of the heart from cardiac injuries
    Publication number: 20050084860
    Abstract: The present invention relates to compounds suitable for the treatment of conditions which may be improved, at least in part, by increasing TNF ? production. The invention further relates to assays for the identification of an individual at increased risk for or suffering from such conditions and to methods of screening compounds for their ability to enhance TNF ? biosysthesis.
    Type: Application
    Filed: November 30, 2002
    Publication date: April 21, 2005
    Inventors: Franz-Werner Kluxen, Bernd Hentsch, Thomas Ehring, Marian Brandle, Jorg Hoheisel, Marcus Frohme, Dimitri Zubakov
  • Use of pde v inhibitors
    Publication number: 20030022906
    Abstract: The invention relates to the use of a highly penis-specific PDE V inhibitor, or a physiologically acceptable salt or solvate thereof, for the production of a medicament for the treatment of erectile dysfunction in males, without the previous circulatory side effects caused by PDE V inhibitors, in particular, with concomitant administration of vasodilators, whose mode of action is by means of the NO/cGMP system.
    Type: Application
    Filed: September 3, 2002
    Publication date: January 30, 2003
    Inventors: Marian Brandle, Thomas Ehring, Claudia Wilm